Clinical Trials Browser

OTHER × sintilimab × Genitourinary × Clear all

NCT06523049 2024-07-26

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT04958473 2021-07-12

SAARCC

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04146831 2020-05-12

Sintilimab in FH-deficient Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell